Characterization of NMO and NMOSD Patients with a Late Onset

Characterization of NMO and NMOSD Patients with a Late Onset

Bibliografiske detaljer
Main Authors:	Collongues, N, Marignier, R, Jacob, A, Siva, A, Paul, F, Zephir, H, Leite, M, Akman-Demir, G, Elsone, L, Jarius, S, Papeix, C, Mutch, K, Saip, S, Wildemann, B, Kitley, J, Karabudak, R, Aktas, O, Kuscu, D, Altintas, A, Palace, J, Confavreux, C, De Seze, J
Format:	Journal article
Udgivet:	2013

Lignende værker

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
af: Collongues, N, et al.
Udgivet: (2013)

RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES
af: Elsone, L, et al.
Udgivet: (2014)

NMO-IgG in the diagnosis of neuromyelitis optica.
af: Jarius, S, et al.
Udgivet: (2007)

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes
af: Juryńczyk, M, et al.
Udgivet: (2015)

Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab.
af: Kitley, J, et al.
Udgivet: (2014)

Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab
af: Kitley, J, et al.
Udgivet: (2014)

A novel sensitive assay for aqueporin-4 antibodies (NMO-IgG)
af: Waters, P, et al.
Udgivet: (2007)

Glycine receptor antibody — a marker for NMO/ NON-MS demyelination?
af: Hamid, S, et al.
Udgivet: (2015)

Revised diagnostic criteria for neuromyelitis optica--incorporation of NMO-IgG status.
af: Jarius, S, et al.
Udgivet: (2007)

Resting-state functional MRI demonstrates brain network reorganization in neuromyelitis optica spectrum disorder (NMOSD).
af: Kévin Bigaut, et al.
Udgivet: (2019-01-01)

MOG-IGG IN NMO AND NMO-LIKE DISORDERS
af: Luppe, S, et al.
Udgivet: (2014)

LONG TERM OUTCOME IN NEUROMYELITIS OPTICA: LESSONS FROM 6 YEARS OF THE UK NMO STUDY
af: Jacob, A, et al.
Udgivet: (2009)

Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing
af: Jarius, S, et al.
Udgivet: (2007)

Spinal cord MRI features in neuromyelitis optica (NMO): characteristics and relationship with severity and recovery in longitudinally extensive transverse myelitis (LETM) attacks
af: Murchison, A, et al.
Udgivet: (2013)

Overlapping CNS inflammatory diseases: differentiating features of NMO and MS.
af: Juryńczyk, M, et al.
Udgivet: (2015)

Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients
af: Akman-Demir, G, et al.
Udgivet: (2008)

A case of MS, ADEM, NMO or all three?
af: Pomeroy, I, et al.
Udgivet: (2005)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
af: Littleton, E, et al.
Udgivet: (2006)

Real-life study to assess effectiveness and safety of eculizumab in patients with neuromyelitis optica spectrum disorders in France: protocol for ECUP4, an observational study
af: Romain Marignier, et al.
Udgivet: (2024-01-01)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
af: Downer, J, et al.
Udgivet: (2012)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
af: Downer, J, et al.
Udgivet: (2012)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
af: Kitley, J, et al.
Udgivet: (2014)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
af: Kitley, J, et al.
Udgivet: (2014)

NMO-IgG/Aqp4-Ab belongs to the IgG1 subclass and activates complement in vitro
af: Jarius, S, et al.
Udgivet: (2007)

Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG–positive NMOSD
af: Shosha, E, et al.
Udgivet: (2018)

The two faces of NMO
af: Schwarz, B, et al.
Udgivet: (2017)

Classifying the antibody-negative NMO syndromes: Clinical, imaging, and metabolomic modeling
af: Yeo, T, et al.
Udgivet: (2019)

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
af: Kitley, J, et al.
Udgivet: (2012)

Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
af: Waters, P, et al.
Udgivet: (2012)

Characterization of the Human NMO-1 gene at 1q43 and genomic organisation of the region. NMO-1.
af: Halford, S, et al.
Udgivet: (2000)

Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
af: Matthews, L, et al.
Udgivet: (2013)

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
af: Juryńczyk, M, et al.
Udgivet: (2016)

Seasonal pattern of variation in neuromyelitis optica relapses
af: Elsone, L, et al.
Udgivet: (2012)

Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience
af: Mohammad Hossein Harirchian, et al.
Udgivet: (2015-02-01)

Neuromyelitis Optica (NMO) — Study Review
af: Justyna Chojdak-Łukasiewicz
Udgivet: (2021-06-01)

Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.
af: Piccolo, L, et al.
Udgivet: (2016)

NMO-DBr: the Brazilian Neuromyelitis Optica Database System
af: Marco A. Lana-Peixoto, et al.
Udgivet: (2011-08-01)

An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assays.
af: Romana Höftberger, et al.
Udgivet: (2013-01-01)

The clinical profile of NMOSD in Australia and New Zealand
af: Bukhari, W, et al.
Udgivet: (2020)

NMO in pediatric patients: brain involvement and clinical expression
af: Joaquín A. Peña, et al.
Udgivet: (2011-02-01)